RO7119929
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7119929, covering 2024-12-09 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases [Phase 1]